Company: NIVFW
Filing Date: 2025-05-01
Form Type: F-1/A
Source: 0001213900-25-038045
Chunk: 34

Company: NewGenIvf Group Ltd
Filing Date: 2025-05-01
Form: F-1/A
Chunk 34
---
 |     | 2,339,147 |
| Total Indebtedness                     |     |     | 5,059,501 |

19

Dilution The following information is presented as of December 31, 2024:

|                                                                            |     | Existing shareholder 
 31/12/2024           |          |   |
|:---------------------------------------------------------------------------|:----|:---------------------|---------:|:--|
| Total comprehensive income attributable to the shareholders of the company |     | $                    | (498,480 | ) |
| Earning per share – basic                                                  |     |                      |    (1.32 | ) |
| - diluted                                                                  |     |                      |    (0.64 | ) |
| Weighted average shares outstanding – Basic                                |     |                      |  358,108 |   |
| - Diluted                                                                  |     |                      |  743,323 |   |

Implications of being a “Foreign Private Issuer” We are subject to the information reporting requirements of the Exchange Act that are applicable to “foreign private issuers,” and under those requirements, we file reports with the SEC. As a foreign private issuer, we are not subject to the same requirements that are imposed upon U.S. domestic issuers by the SEC. Under the Exchange Act, we are subject to reporting obligations that, in certain respects, are less detailed and less frequent than those of U.S. domestic reporting companies. For example, we are not required to issue quarterly reports, proxy statements that comply with the requirements applicable to U.S. domestic reporting companies or individual executive compensation information that is as detailed as that required of U.S. domestic reporting companies. We also have four months after the end of each fiscal year to file our annual report with the SEC and are not required to file current reports as frequently or promptly as U.S. domestic reporting companies. Our officers, directors and principal shareholders are exempt from the requirements to report transactions in our equity securities and from the short-swing profit liability provisions contained in Section 16 of the Exchange Act. As a foreign private issuer, we are not subject to the requirements of Regulation FD (Fair Disclosure) promulgated under the Exchange Act. In addition, as a foreign private issuer, we are permitted to follow certain home country corporate governance practices instead of those otherwise required under the rules of Nasdaq for domestic U.S. issuers and are not required to be compliant with all Nasdaq rules as of the date of our initial listing on Nasdaq as would